all news

Our partners are building great companies. We love to share their stories.

Wed, 21 Feb 2024 GlobeNewswire

Paratus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive Officer

Fri, 16 Feb 2024 Newswire

Proof and Hello Prenup Announce Strategic Partnership

Thu, 15 Feb 2024 PR Newswire

Freenome Raises $254 Million in New Funding

Tue, 13 Feb 2024 PR Newswire

1. Roche Enters Into Collaboration Agreement with PathAI

Fri, 9 Feb 2024 aurontx.com

Auron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its novel Aurigin Platform

Thu, 8 Feb 2024 Tech Inside Out (PR Newswire)

Dr. Robert Langer to Receive 2023 Dr. Paul Janssen Award for Groundbreaking Research in Biomedical Compounds for Drug Delivery

Thu, 8 Feb 2024 GlobeNewswire

Alector Announces First Patient Dosed in Phase 2 Clinical Trials of Patients with Early Alzheimer's Disease

Tue, 6 Feb 2024 PR Newswire

Tausight Announces New Integration with Crowdstrike to Advance Cybersecurity for Healthcare

Thu, 1 Feb 2024 PR Newswire

Cohere Health Raises $50M in Equity

Tue, 30 Jan 2024 GlobeNewswire

Jnana Therapeutics Announces Positive Clinical Proof Concept

Tue, 30 Jan 2024 businesswire.com

Tectonic Therapeutic and AVROBIO Announce Merger

Wed, 17 Jan 2024 citybiz

Thirty Madison Appoints Nirveek De As Chief Product Officer

Tue, 16 Jan 2024 GlobeNewswire News Room

5. Dewpoint Therapeutics Awarded Target ALS Grant for Development of C-mods for ALS

Tue, 16 Jan 2024 BioSpace

3. Tome Biosciences to Collaborate with Genevant Sciences to Develop Gene Editing Therapeutic for Rare Liver Disorder

Wed, 10 Jan 2024 businesswire.com

Adimab Announces Substantial Expansion of Research Campus

Sun, 7 Jan 2024 Yahoo Finance

Dewpoint Therapeutics Filed Multiple Patent Applications with the US Patent Office on Novel Composition of Matter for the Treatment of ALS

Fri, 5 Jan 2024 PR Newswire

Vico Therapeutics Announces $60 million Series B Financing to Advance Clinical-Stage Program for Rare Neurological Diseases

Thu, 4 Jan 2024 Axios

UpDoc emerges from stealth with a consortium of partners pioneering the world’s first AI Assistant that manages medical conditions

Thu, 4 Jan 2024 GlobeNewswire

Faraday Pharmaceuticals Announces Agreement with FDA

Wed, 3 Jan 2024 BioSpace

QurAlis Strengthens Global Presence With Opening of European Headquarters That Includes R&D Manufacturing

Wed, 3 Jan 2024 businesswire.com

Harvey J. Berger, M.D. Joins Kojin Therapeutics as Chairman, President, and Chief Executive Officer

Wed, 3 Jan 2024 GlobeNewswire

Tome Biosciences Acquires Replace Therapeutics

Fri, 22 Dec 2023 Business Wire

Lyndra Therapeutics Raises $101 Million in Series E Funding

Tue, 12 Dec 2023 GlobeNewswire

Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform

Fri, 8 Dec 2023 FierceBiotech

Ajax Health announces formation of new company, Cortex, to develop a treatment for atrial fibrillation

Mon, 4 Dec 2023 businesswire.com

Seismic Therapeutics secures a series B funding totaling $121 million

Thu, 30 Nov 2023 Business Wire

Ajax Health Establishes New Platform with KKR and Hologic to Accelerate Innovation in the Lung Cancer Disease Category

Wed, 29 Nov 2023 KSQ Therapeutics

3. KSQ Therapeutics Announces FDA Clearance of IND Application for Engineered Tumor Infiltrating Lymphocyte Therapy

Wed, 29 Nov 2023 Neumora Therapeutics, Inc.

2. Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study

Tue, 28 Nov 2023 businesswire.com

1. Tectonic Therapeutic Announces Start of First Clinical Program for GPCR-Targeted Biologic